DE102005028453A1 - Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen - Google Patents

Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen Download PDF

Info

Publication number
DE102005028453A1
DE102005028453A1 DE102005028453A DE102005028453A DE102005028453A1 DE 102005028453 A1 DE102005028453 A1 DE 102005028453A1 DE 102005028453 A DE102005028453 A DE 102005028453A DE 102005028453 A DE102005028453 A DE 102005028453A DE 102005028453 A1 DE102005028453 A1 DE 102005028453A1
Authority
DE
Germany
Prior art keywords
receptor
sperm
inhibitor
ligand
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102005028453A
Other languages
German (de)
English (en)
Inventor
Ingrid Dr. Boekhoff
Thomas Prof. Dr. Gudermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philipps Universitaet Marburg
Original Assignee
Philipps Universitaet Marburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philipps Universitaet Marburg filed Critical Philipps Universitaet Marburg
Priority to DE102005028453A priority Critical patent/DE102005028453A1/de
Priority to PCT/DE2006/001033 priority patent/WO2006133691A1/fr
Publication of DE102005028453A1 publication Critical patent/DE102005028453A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE102005028453A 2005-06-17 2005-06-17 Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen Withdrawn DE102005028453A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE102005028453A DE102005028453A1 (de) 2005-06-17 2005-06-17 Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen
PCT/DE2006/001033 WO2006133691A1 (fr) 2005-06-17 2006-06-14 Procede pour determiner et influer sur la fertilite de mammiferes males et sur celle de l'homme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005028453A DE102005028453A1 (de) 2005-06-17 2005-06-17 Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen

Publications (1)

Publication Number Publication Date
DE102005028453A1 true DE102005028453A1 (de) 2006-12-28

Family

ID=36990829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102005028453A Withdrawn DE102005028453A1 (de) 2005-06-17 2005-06-17 Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen

Country Status (2)

Country Link
DE (1) DE102005028453A1 (fr)
WO (1) WO2006133691A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150087610A1 (en) * 2012-03-20 2015-03-26 Monell Chemcial Senses Center Method of Modifying Fertility

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410816B1 (fr) * 1989-07-28 1998-01-14 Wisconsin Alumni Research Foundation Détection des protéines séminales liant l'héparine
US5989549A (en) * 1998-06-08 1999-11-23 Immucon Inc. Acrosomal sperm protein and uses thereof
WO2000056144A1 (fr) * 1999-03-23 2000-09-28 University Of Virginia Patent Foundation Antigenes de surface de sperme humain
US20010008764A1 (en) * 1989-07-28 2001-07-19 Roy Ax Fertility-related proteins, and methods of use thereof
US20040191862A1 (en) * 2001-03-07 2004-09-30 Senomyx, Inc. Recombinant methods for expressing a functional sweet (T1R2/T1R3) taste receptor
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor
US6891029B2 (en) * 2000-07-14 2005-05-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Isolated polynucleotide sequences encoding a fertility associated antigen

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410816B1 (fr) * 1989-07-28 1998-01-14 Wisconsin Alumni Research Foundation Détection des protéines séminales liant l'héparine
US20010008764A1 (en) * 1989-07-28 2001-07-19 Roy Ax Fertility-related proteins, and methods of use thereof
US5989549A (en) * 1998-06-08 1999-11-23 Immucon Inc. Acrosomal sperm protein and uses thereof
WO2000056144A1 (fr) * 1999-03-23 2000-09-28 University Of Virginia Patent Foundation Antigenes de surface de sperme humain
US6891029B2 (en) * 2000-07-14 2005-05-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Isolated polynucleotide sequences encoding a fertility associated antigen
US20040191862A1 (en) * 2001-03-07 2004-09-30 Senomyx, Inc. Recombinant methods for expressing a functional sweet (T1R2/T1R3) taste receptor
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor

Also Published As

Publication number Publication date
WO2006133691A1 (fr) 2006-12-21

Similar Documents

Publication Publication Date Title
DE69911400T2 (de) Zusammensetzungen enhaltende 5-hydroxyindol als Modulator eines nikotinischen Rezeptors
Kinney et al. Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus
DE69836229T2 (de) Zusammensetzungen von durch niedervolt aktivierten kalziumkanälen und verfahren
EP2948135B1 (fr) Compositions et méthodes de traitement de troubles envahissants du développement
US10413541B2 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
Quirion et al. The onset and progression of hippocampal synaptic plasticity deficits in the Q175FDN mouse model of Huntington disease
Chris Muly et al. Distribution of D 1 and D 5 dopamine receptors in the primate and rat basolateral amygdala
Rittenhouse et al. Role of N‐and L‐type calcium channels in depolarization‐induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and nerve terminals
DE602004013431T2 (de) Identifikation von therapeutische verbindungen.
DE102005028453A1 (de) Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen
DE60002984T2 (de) Neue verwendung von orexinrezeptorantagonisten
DE60129015T2 (de) Verfahren zur erkennung von entzündungen und entzündungsbedingungen
Bairam et al. Developmental pattern of M1 and M2 muscarinic gene expression and receptor levels in cat carotid body, petrosal and superior cervical ganglion
DE69736893T2 (de) Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu
Meneghini et al. The β2V287L nicotinic subunit linked to sleep-related epilepsy differently affects fast-spiking and regular spiking somatostatin-expressing neurons in murine prefrontal cortex
DE60303315T2 (de) Screening-verfahren und daraus erhaltene antitumormittel
Pottorf et al. Mechanisms of calcium buffering in adrenergic neurones and effects of ageing: testing the limits of homeostasis
Waldvogel et al. Variable colocalisation of GABAA receptor subunits and glycine receptors on neurons in the human hypoglossal nucleus
DE60210783T2 (de) Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose
WO2004005540A2 (fr) Utilisations de substances qui se lient a ngal pour le diagnostic et le traitement de maladies cancereuses
EP1023445B1 (fr) Facteur de croissance derive de la cadherine et son utilisation
Doroshenko et al. Pertussis-toxin-sensitive inhibition by (-) baclofen of Ca signals in bovine chromaffin cells
EP1386615A1 (fr) Antagonistes du récepteur EG-VEGF/prokineticin 2
DE10234901A1 (de) Verwendung von am Mrp4 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
Tzeng Regulation of Synapse Refinement by Visual Experience-Dependent Transcription

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
R005 Application deemed withdrawn due to failure to request examination

Effective date: 20120619